Late PET/CT Findings of COVID-19 Pneumonia With 2 Different Radiopharmaceuticals in a Patient PSMA Avidity Higher Than FDGs
dc.contributor.author | Sahin, Ozlem | |
dc.contributor.author | Kaya, Bugra | |
dc.contributor.author | Aydin, Zeynep | |
dc.contributor.author | Karaagac, Mustafa | |
dc.contributor.author | Kanyilmaz, Gul | |
dc.date.accessioned | 2024-02-23T14:21:19Z | |
dc.date.available | 2024-02-23T14:21:19Z | |
dc.date.issued | 2021 | |
dc.department | NEÜ | en_US |
dc.description.abstract | We present the Ga-68-PSMA and F-18-FDG PET/CT findings comparatively of a 67-year-old prostate cancer and malignant melanoma patient who had COVID-19 pneumonia 3 months ago. In Ga-68-PSMA PET/CT, ground-glass opacities showing markedly increased PSMA uptake were observed in the patient's lungs. It was learned that the patient had COVID-19 pneumonia 3 months ago and was treated in the intensive care unit for 13 days. In F-18-FDG PET/CT, FDG uptake was minimal in the same areas. In the midterm period after COVID-19 pneumonia, lung PSMA uptake is more intense than FDG, which may help better understand the disease's healing phase. | en_US |
dc.identifier.doi | 10.1097/RLU.0000000000003720 | |
dc.identifier.endpage | E522 | en_US |
dc.identifier.issn | 0363-9762 | |
dc.identifier.issn | 1536-0229 | |
dc.identifier.issue | 10 | en_US |
dc.identifier.pmid | 34477606 | en_US |
dc.identifier.scopus | 2-s2.0-85115901102 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | E521 | en_US |
dc.identifier.uri | https://doi.org/10.1097/RLU.0000000000003720 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/13542 | |
dc.identifier.volume | 46 | en_US |
dc.identifier.wos | WOS:000697238000014 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Clinical Nuclear Medicine | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Fdg | en_US |
dc.subject | Psma | en_US |
dc.subject | Pet/Ct | en_US |
dc.subject | Covid-19 | en_US |
dc.subject | Ground-Glass Opacities | en_US |
dc.title | Late PET/CT Findings of COVID-19 Pneumonia With 2 Different Radiopharmaceuticals in a Patient PSMA Avidity Higher Than FDGs | en_US |
dc.type | Editorial Material | en_US |